Arcatron Mobility is a medical equipment startup based in Pune, India, that makes mobility and assisted-living aids under the Frido brand.

This Startup Deep Dive explains what Arcatron Mobility does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Arcatron Mobility in Brief

• What it is: Arcatron Mobility is an Indian Mobility aids, medical devices company based in Pune.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Arcatron Mobility sells mobility and body-support products under the Frido brand.
• The range spans wheelchairs and mobility assist devices, orthopaedic insoles, ergonomic cushions, backrests, coccyx seat cushions and neck and sleep pillows.
• The original FRIDO wheelchair has a stainless steel body, height adjustment for use over toilets and beds, a waterproof seat and a Fold & Go suitcase pack in about 60 seconds.
• Funding: Not disclosed for 2021 and 2024 rounds; one report puts total angel and seed funding at about $646K before the OrbiMed round.

Arcatron Mobility Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Arcatron Mobility?

Arcatron Mobility operates in the Mobility aids, medical devices space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Arcatron Mobility.

• Arcatron Mobility sells mobility and body-support products under the Frido brand.
• The range spans wheelchairs and mobility assist devices, orthopaedic insoles, ergonomic cushions, backrests, coccyx seat cushions and neck and sleep pillows.
• The original FRIDO wheelchair has a stainless steel body, height adjustment for use over toilets and beds, a waterproof seat and a Fold & Go suitcase pack in about 60 seconds.
• Products are sold on e-commerce platforms, its own website and in over 1,000 stores across India.

The Origin Story of Arcatron Mobility

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Ganesh Sonawane, Arif Khan, Laxmikant Banjarey, Kunal Kamble, Dewraj Barua.
• The founders studied at NIT Kozhikode; in 2011 they won a college contest themed Design for Disabled with a commode-compatible wheelchair.
• They developed the prototype from 2012 as a weekend project until early 2014, then saw its potential for disabled users and senior citizens.
• The company was formally founded on 4 June 2015 in Pune.
• Founder lists differ: recent coverage names Ganesh Sonawane (CEO) and Arif Khan; a 2020 profile names Sonawane, Laxmikant Banjarey, Kunal Kamble and Dewraj Barua; a database lists Khan, Kamble, Baruah and Sonawane.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Mobility aids, medical devices sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2011: wins college Design for Disabled contest with a commode-compatible wheelchair.
• 4 June 2015: company founded; 2016: best startup award from Google India (reported).
• Seed convertible note of about $100K led by Indian Angel Network members for R&D, patents and field trials (reported).
• July 2021: growth financing through revenue-based financing platform Klub; company said it grew at 100 percent monthly CMGR.
• February 2022: Frido brand incorporated to sell body support products (reported).
• February 2024: growth capital from OrbiMed; OrbiMed's Dr Sunny Sharma and Sumona Chakraborty join the board.

Arcatron Mobility Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Seed convertible note, about $100K, led by Vaibhav Kulkarni and Sudhir Mehta of Indian Angel Network (reported; another report cites $61.3K from IAN in April 2021).
• Revenue-based financing via Klub, July 2021, undisclosed.
• Growth round, February 2024, undisclosed, led by OrbiMed with BL Taparia Family Office, Chona Family Office, MGA Ventures and the founders.

How Does Arcatron Mobility Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Direct-to-consumer and retail sales of physical mobility and ergonomic products under the Frido brand.
• Wheelchair pricing ranged from Rs 9,500 to Rs 36,000 depending on model (2020 profile).
• Multi-channel distribution: e-commerce marketplaces, own website and over 1,000 offline stores.

The Numbers: Arcatron Mobility Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Revenue, profit and loss were not found in sources read.
• Over 1,000 retail stores stocking Frido products (company-stated).

Market Opportunity for Arcatron Mobility

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• The founder's view is that demand is shifting from generic comfort to problem-specific functional wellness products.
• Targets people with mobility limits, back pain and posture issues, plus general ergonomic buyers.

Technology and Product at Arcatron Mobility

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• In-house product design and engineering, with ISO and CE certifications on the wheelchair.

Team and Culture at Arcatron Mobility

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Ganesh Sonawane is co-founder and CEO.
• Arif Khan is named as co-founder in recent funding coverage.
• OrbiMed representatives joined the board in 2024.

Arcatron Mobility Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Arcatron Mobility

• Round sizes for 2021 and 2024 are undisclosed and founding year and founder lists differ across sources.
• Consumer ergonomic products are low-barrier and face many rivals on marketplaces.
• No financials were found in sources read, so profitability is unknown.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Arcatron Mobility Growth Outlook: What to Watch

• OrbiMed funds are meant for R&D, new products and stronger branding and marketing (company-stated).
• Founder frames growth around functional wellness products.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Arcatron Mobility can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Arcatron Mobility Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Arcatron Mobility

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Arcatron Mobility.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Arcatron Mobility

Studying a company in the Mobility aids, medical devices space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Arcatron Mobility.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Arcatron Mobility as a Startup

• Customer clarity: Can Arcatron Mobility name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Arcatron Mobility is part of India’s growing Mobility aids, medical devices ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Arcatron Mobility FAQs: Frequently Asked Questions

What is Arcatron Mobility?

Arcatron Mobility is a medical equipment startup based in Pune, India, that makes mobility and assisted-living aids under the Frido brand. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Arcatron Mobility?

Arcatron Mobility was founded by Ganesh Sonawane, Arif Khan, Laxmikant Banjarey, Kunal Kamble, Dewraj Barua, and the company reports a founding year of 2015 (founded 4 June 2015 per a profile; one database says 2012, when the prototype work began).

How much funding has Arcatron Mobility raised?

Not disclosed for 2021 and 2024 rounds; one report puts total angel and seed funding at about $646K before the OrbiMed round. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Arcatron Mobility make money?

Arcatron Mobility earns revenue from its Mobility aids, medical devices products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Arcatron Mobility?

Reported rivals include Superfeet, PROFOOT, Tread Labs. See the competitor comparison above for how they differ.

What are the main risks for Arcatron Mobility?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Aye Finance — Aye Finance: Rs 5,534 crore AUM and Rs 175 crore FY25 profit | Lissun — LISSUN: from mental health app to child development centres. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.